Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Healthcare services beat-and-raise candidate: Q1 2026 revenue and adjusted EPS beat estimates, full-year guidance was raised, VITAS growth remained strong with admissions up 6.9%, and the company added a new $300M buyback authorization.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong Cash Flow ⢠Rising Leverage ⢠Weakening Liquidity CHE remains highly profitable and cash-generative, but rising leverage, weaker liquidity, and richer valuation multiples warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Monthly decline ⢠Support holding ⢠Resistance overhead Support Level: $515â$520 Resistance Level: $533; stronger at $540â$552 CHE is bearish over the last month, with support at $515â$520 and a recovery above $533 needed to improve momentum.
Sentiment & News
Key News Insights: ⢠Fiduciary investigations ⢠Institutional buying ⢠Dividend increase Chemed faces fiduciary-duty investigations despite institutional buying and a 17% dividend increase, creating mixed near-term sentiment.
AI Summary
CHE is now chiefly a VITAS-driven execution investment: sustained admissions, census growth, and margin expansion could justify its premium valuation, but any slowdownâespecially without a Roto-Rooter margin recoveryâcould compress the 25â26x earnings multiple amid rising leverage and governance scrutiny. Investors should await confirmation that VITAS operating leverage remains durable and Roto-Rooter restores incremental profitability before adding aggressively.
Description
Chemed Corporation delivers hospice and palliative care through a multidisciplinary network of clinicians, aides, social workers, clergy and volunteers across the United States under its VITAS segment, and provides plumbing, drain, excavation and water-restoration services to residential and commercial customers via company branches, independent contractors and franchisees under its Roto-Rooter segment. The company operates these two distinct businesses from its headquarters in Cincinnati and has been incorporated since 1970.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Apr 28 | May 5 | CHE | Chemed Corporation | Healthcare services beat-and-raise candidate: Q1 2026 revenue and adjusted EPS beat estimates, full-year guidance was raised, VITAS growth remained strong with admissions up 6.9%, and the company added a new $300M buyback authorization. | Closed | +1.5% |